Human papillomavirus typing of invasive cervical cancers in Italy

<p>Abstract</p> <p>Background</p> <p>Human papilloma viruses (HPV) are the necessary cause of invasive cervical cancer (ICC). Of the many different types identified so far, only a few of them account for the great majority of cases worldwide, with geographical differenc...

Full description

Bibliographic Details
Main Authors: Parenti Anna, Bertorelle Roberta, Trevisan Rossana, Salamanca Helena, Del Mistro Annarosa, Bonoldi Emanuela, Zambon Paola, Minucci Daria
Format: Article
Language:English
Published: BMC 2006-12-01
Series:Infectious Agents and Cancer
Online Access:http://www.infectagentscancer.com/content/1/1/9
_version_ 1819178866319556608
author Parenti Anna
Bertorelle Roberta
Trevisan Rossana
Salamanca Helena
Del Mistro Annarosa
Bonoldi Emanuela
Zambon Paola
Minucci Daria
author_facet Parenti Anna
Bertorelle Roberta
Trevisan Rossana
Salamanca Helena
Del Mistro Annarosa
Bonoldi Emanuela
Zambon Paola
Minucci Daria
author_sort Parenti Anna
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Human papilloma viruses (HPV) are the necessary cause of invasive cervical cancer (ICC). Of the many different types identified so far, only a few of them account for the great majority of cases worldwide, with geographical differences in their distribution. Data on the local distribution are now of interest in view of the soon-to-come introduction of HPV type-specific prophylactic vaccines.</p> <p>Results</p> <p>We have investigated HPV type distribution in samples of 48 ICC cases occurred in women living in North-East Italy in the years 1997–1999. Cases were extracted from the Venetian Tumour Registry files, as incident cases whose specimens had been processed in two Pathology Departments. Search and typing were performed by polymerase chain reaction (PCR) using GP5+/GP6+ primers, followed by direct sequencing or reverse dot blot. Three cases were PCR negative using the housekeeping primers and hence excluded. One case was negative by all HPV tests used. HPV 16 was present in 32 (72.7%) cases, as single infection in 28, in mixed infection in 4. Of the 44 positive cases, HPV 16 and HPV 18 accounted for 33 (75%), as single or mixed infections. The other high risk HPV types accounted for 11 (25%) of the remaining infections. Of the 32 HPV 16 positive cases, sequencing of the E6 gene could be performed in 25; the prototype isolate was identified in 7, and the variant T350G in 18; in 4 cases one or more additional mutations were present.</p> <p>Conclusions</p> <p>Our results suggest that HPV 16 has a very high prevalence among women with invasive cervical cancer in Italy; therefore, the use of a prophylactic vaccine for HPV types 16 and 18 could prevent up to 75% of invasive cervical cancers in Italy.</p>
first_indexed 2024-12-22T21:49:21Z
format Article
id doaj.art-b65d6ab040d145f9b7778f3d0dc680ea
institution Directory Open Access Journal
issn 1750-9378
language English
last_indexed 2024-12-22T21:49:21Z
publishDate 2006-12-01
publisher BMC
record_format Article
series Infectious Agents and Cancer
spelling doaj.art-b65d6ab040d145f9b7778f3d0dc680ea2022-12-21T18:11:25ZengBMCInfectious Agents and Cancer1750-93782006-12-0111910.1186/1750-9378-1-9Human papillomavirus typing of invasive cervical cancers in ItalyParenti AnnaBertorelle RobertaTrevisan RossanaSalamanca HelenaDel Mistro AnnarosaBonoldi EmanuelaZambon PaolaMinucci Daria<p>Abstract</p> <p>Background</p> <p>Human papilloma viruses (HPV) are the necessary cause of invasive cervical cancer (ICC). Of the many different types identified so far, only a few of them account for the great majority of cases worldwide, with geographical differences in their distribution. Data on the local distribution are now of interest in view of the soon-to-come introduction of HPV type-specific prophylactic vaccines.</p> <p>Results</p> <p>We have investigated HPV type distribution in samples of 48 ICC cases occurred in women living in North-East Italy in the years 1997–1999. Cases were extracted from the Venetian Tumour Registry files, as incident cases whose specimens had been processed in two Pathology Departments. Search and typing were performed by polymerase chain reaction (PCR) using GP5+/GP6+ primers, followed by direct sequencing or reverse dot blot. Three cases were PCR negative using the housekeeping primers and hence excluded. One case was negative by all HPV tests used. HPV 16 was present in 32 (72.7%) cases, as single infection in 28, in mixed infection in 4. Of the 44 positive cases, HPV 16 and HPV 18 accounted for 33 (75%), as single or mixed infections. The other high risk HPV types accounted for 11 (25%) of the remaining infections. Of the 32 HPV 16 positive cases, sequencing of the E6 gene could be performed in 25; the prototype isolate was identified in 7, and the variant T350G in 18; in 4 cases one or more additional mutations were present.</p> <p>Conclusions</p> <p>Our results suggest that HPV 16 has a very high prevalence among women with invasive cervical cancer in Italy; therefore, the use of a prophylactic vaccine for HPV types 16 and 18 could prevent up to 75% of invasive cervical cancers in Italy.</p>http://www.infectagentscancer.com/content/1/1/9
spellingShingle Parenti Anna
Bertorelle Roberta
Trevisan Rossana
Salamanca Helena
Del Mistro Annarosa
Bonoldi Emanuela
Zambon Paola
Minucci Daria
Human papillomavirus typing of invasive cervical cancers in Italy
Infectious Agents and Cancer
title Human papillomavirus typing of invasive cervical cancers in Italy
title_full Human papillomavirus typing of invasive cervical cancers in Italy
title_fullStr Human papillomavirus typing of invasive cervical cancers in Italy
title_full_unstemmed Human papillomavirus typing of invasive cervical cancers in Italy
title_short Human papillomavirus typing of invasive cervical cancers in Italy
title_sort human papillomavirus typing of invasive cervical cancers in italy
url http://www.infectagentscancer.com/content/1/1/9
work_keys_str_mv AT parentianna humanpapillomavirustypingofinvasivecervicalcancersinitaly
AT bertorelleroberta humanpapillomavirustypingofinvasivecervicalcancersinitaly
AT trevisanrossana humanpapillomavirustypingofinvasivecervicalcancersinitaly
AT salamancahelena humanpapillomavirustypingofinvasivecervicalcancersinitaly
AT delmistroannarosa humanpapillomavirustypingofinvasivecervicalcancersinitaly
AT bonoldiemanuela humanpapillomavirustypingofinvasivecervicalcancersinitaly
AT zambonpaola humanpapillomavirustypingofinvasivecervicalcancersinitaly
AT minuccidaria humanpapillomavirustypingofinvasivecervicalcancersinitaly